Area of research
Applied Microbiology and Biotechnology · Molecular Medicine
Research interest
Research interests include Antibiotic Use and Resistance, Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, and Antibiotics Pharmacokinetics and Efficacy.
WHO global research priorities for antimicrobial resistance in human health
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Tackling the threat of antimicrobial resistance in neonates and children: outcomes from the first WHO-convened Paediatric Drug Optimisation exercise for antibiotics
The WHO AWaRe Antibiotic Book: providing guidance on optimal use and informing policy
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic
Methicillin-Resistant Staphylococcus aureus: An Update on Prevention and Control in Acute Care Settings
COVID-19: don't neglect antimicrobial stewardship principles!
Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool
ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers
A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial
ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus
Do medical students feel prepared to prescribe antibiotics responsibly? Results from a cross-sectional survey in 29 European countries
What is antimicrobial stewardship?
Variation in Empiric Coverage Versus Detection of Methicillin-Resistant<i>Staphylococcus aureus</i>and<i>Pseudomonas aeruginosa</i>in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers
An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model
Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006–2010
Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans Healthcare Administration
Development of an Antibiotic Spectrum Score Based on Veterans Affairs Culture and Susceptibility Data for the Purpose of Measuring Antibiotic De-Escalation: A Modified Delphi Approach
A Simulation-Based Assessment of Strategies to Control Clostridium Difficile Transmission and Infection
Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system
Relationships Between the Importation, Transmission, and Nosocomial Infections of Methicillin-Resistant Staphylococcus aureus: An Observational Study of 112 Veterans Affairs Medical Centers
Parenteral to Oral Conversion of Fluoroquinolones: Low-Hanging Fruit for Antimicrobial Stewardship Programs?